Despite ongoing impacts of COVID-19 variants around the world, we are all working hard to emerge from the pandemic with an optimistic outlook. For members of ASPIRE eager to return to the traditional companionship and collegiality of our annual congresses, the future looks far brighter than it has for the past couple of years.
ASPIRE is a relatively young, but dynamic society of scientists, doctors, nurses and counsellors dedicated to excellence in delivering best practice to help infertile people achieve their hopes of parenthood.
Adelaide, South Australia beckons us all for the 2023 ASPIRE Congress, the first face-to-face conference for our organisation since Hong Kong in 2019. With outstanding commitment and adaptability, ASPIRE presented virtual Congresses in 2021 and again this year with both events welcoming on-line participants from around the world to discuss latest advances in the diagnosis and treatment of infertility.
So, it is with building excitement that we plan for the Adelaide Congress from 7 to 10 September 2023 when we can get together again to share knowledge and ideas in our on-going commitment to develop and advance fertility services in the Asia-Pacific region.
Adelaide figures prominently among many milestones in the evolution of assisted reproduction, and over the years many international clinicians and scientists have visited the city for collaborative work. Our Congress next year will continue this focus as world leaders in assisted reproductive technology across various disciplines gather in Adelaide to address the theme Welcome Back To Our Future.
The local organising committee led by Professor Louise Hull is putting together a powerful scientific program that will also feature our traditional Pre-Congress meetings and a wonderful, welcoming social program.
I encourage members to set aside the dates to attend the Congress in Adelaide to come together for inspiring discussion that will convert to opportunities to enhance patient care in our individual clinics and workplaces.
President’s message on ASPIRE newsletter Volume 7, Issue 3 (August 2022). Read more here.